From: Significant sequelae after bacterial meningitis in Niger: a cohort study
Sequelae | Exposed | Non exposed | p | Crude RR | 95% CI RR | |||
---|---|---|---|---|---|---|---|---|
n = 67 | % | n = 65 | % | |||||
Functional symptoms | ||||||||
Headache | 67 | 31.3 | 65 | 13.8 | 0.022 | 2.3 | 1.1 | 4.6 |
Asthenia | 65 | 36.9 | 63 | 12.7 | 0.002 | 2.9 | 1.4 | 6.0 |
Vertigo | 67 | 22.4 | 65 | 7.7 | 0.027 | 2.9 | 1.1 | 7.6 |
Hearing loss assessment1 | ||||||||
Bone conduction altered or mixed | 64 | 7.8 | 65 | 7.7 | 1 | 1.2 | 0.4 | 3.8 |
All levels of hearing loss | 67 | 65 | ||||||
- No | 46 | 68.7 | 53 | 81.5 | ||||
- Mild | 8 | 11.9 | 8 | 12.3 | 0.8 | 1.1 | 0.5 | 2.8 |
- Moderate | 6 | 9.0 | 3 | 4.6 | 0.31 | 2.2 | 0.6 | 8.2 |
- Serious | 7 | 10.4 | 1 | 1.5 | 0.031 | 7.1 | 0.9 | 56.0 |
- Moderate/serious | 13 | 19.4 | 4 | 6.2 | 0.034 | 3.1 | 1.1 | 9.1 |
Motor impairment2 | 65 | 12.3 | 64 | 1.6 | 0.033 | 7.8 | 1 | 60.2 |
Neurological3 | 66 | 36.4 | 64 | 20.3 | 0.053 | 1.79 | 1.0 | 3.2 |